[{"Assets_0_Q1_USD":454216000.0,"CommonStockSharesOutstanding_0_Q1_shares":19435000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":30254000.0,"NetIncomeLoss_1_Q1_USD":26011000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":19426000.0,"StockholdersEquity_0_Q1_USD":426835000.0,"EarningsPerShareBasic_1_Q1_USD":1.34,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20190208"}]